DrugPatentWatch Database Preview
Msn - Profile
Email this page to a colleague
» See Plans and PricingDrugs and US Patents for Msn
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Msn | PREGABALIN | pregabalin | CAPSULE;ORAL | 209357-005 | Jul 19, 2019 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Msn | DEFERASIROX | deferasirox | TABLET, FOR SUSPENSION;ORAL | 209878-003 | Nov 20, 2019 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Msn | CLOFARABINE | clofarabine | SOLUTION;INTRAVENOUS | 209775-001 | Dec 6, 2017 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Msn | MOXIFLOXACIN HYDROCHLORIDE | moxifloxacin hydrochloride | TABLET;ORAL | 208682-001 | Sep 22, 2017 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
